These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 29293402)
1. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer. Liang Y; Li Y; Song X; Zhang N; Sang Y; Zhang H; Liu Y; Chen B; Zhao W; Wang L; Guo R; Yu Z; Yang Q Cancer Biol Ther; 2018 Feb; 19(2):120-131. PubMed ID: 29293402 [TBL] [Abstract][Full Text] [Related]
2. LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer. Ma T; Liang Y; Li Y; Song X; Zhang N; Li X; Chen B; Zhao W; Wang L; Yang Q Cell Signal; 2020 Apr; 68():109536. PubMed ID: 31927036 [TBL] [Abstract][Full Text] [Related]
3. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer. Liu XM; Yang B; Han J Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway. Zhu KR; Sun QF; Zhang YQ Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321 [TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer. Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53. Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678 [TBL] [Abstract][Full Text] [Related]
7. LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN. Zhang M; Wang F; Xiang Z; Huang T; Zhou WB Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1464-1472. PubMed ID: 32198770 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway. Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482 [TBL] [Abstract][Full Text] [Related]
9. LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation. Wang X; Liu H; Shi L; Yu X; Gu Y; Sun X Cell Cycle; 2018; 17(4):439-447. PubMed ID: 29527968 [TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Zhang M; Yang L; Hou L; Tang X Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925 [TBL] [Abstract][Full Text] [Related]
11. YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells. Yang YF; Lee YC; Wang YY; Wang CH; Hou MF; Yuan SF Kaohsiung J Med Sci; 2019 Jul; 35(7):408-416. PubMed ID: 31001932 [TBL] [Abstract][Full Text] [Related]
12. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer. Ma D; Chen C; Wu J; Wang H; Wu D Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352 [TBL] [Abstract][Full Text] [Related]
13. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918 [TBL] [Abstract][Full Text] [Related]
14. A Novel Long Non-Coding RNA KMU15 Promotes Growth and Chemoresistance of Bladder Cancer. Huang Y; Luan T; Bao X; Fu S; Li N; Li H; Wang H; Li C; Wang J Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850704 [TBL] [Abstract][Full Text] [Related]
15. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer. Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000 [TBL] [Abstract][Full Text] [Related]
17. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer. Yu J; Jin T; Zhang T Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440 [TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer. Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469 [TBL] [Abstract][Full Text] [Related]
19. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411 [TBL] [Abstract][Full Text] [Related]
20. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer. Li HP; Yang TZ; Wei L; Ge YF; Meng QS Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]